Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urogenital atrophy.

K H Brown, C B Hammond

    Obstetrics and Gynecology Clinics of North America
    |March 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Postmenopausal urogenital atrophy is common and multifactorial. Estrogen therapy can alleviate symptoms but requires careful monitoring for adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2021
    Same author

    Intestinal microbiota lipid metabolism varies across rainbow trout (Oncorhynchus mykiss) phylogeographic divide.

    Journal of applied microbiology·2018
    Same author

    Comparison of breast milk vitamin A concentration measured in fresh milk by a rapid field assay (the iCheck FLUORO) with standard measurement of stored milk by HPLC.

    European journal of clinical nutrition·2014
    Same author

    Shared acquired genomic changes in zebrafish and human T-ALL.

    Oncogene·2011
    Same author

    Acceptability of complementary foods and breads prepared from zinc-fortified cereal flours among young children and adults in Senegal.

    Journal of food science·2011
    Same author

    The time of day and the interval since previous meal are associated with plasma zinc concentrations and affect estimated risk of zinc deficiency in young children in Peru and Ecuador.

    European journal of clinical nutrition·2010
    Same journal

    Bridging Science and Practice in Gender-Affirming Care: A Compendium for Gynecologists.

    Obstetrics and gynecology clinics of North America·2026
    Same journal

    Evidence, Clinical Expertise, and Research Gaps in Gender-Affirming Care.

    Obstetrics and gynecology clinics of North America·2026
    Same journal

    Evaluation and Management of the Pediatric Gender-Diverse Patient.

    Obstetrics and gynecology clinics of North America·2026
    Same journal

    Expanding Access to Cervical Cancer Screening for Transgender and Nonbinary Individuals.

    Obstetrics and gynecology clinics of North America·2026
    Same journal

    Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women.

    Obstetrics and gynecology clinics of North America·2026
    Same journal

    Contraceptive Needs of the Transmasculine Patient.

    Obstetrics and gynecology clinics of North America·2026
    See all related articles

    Area of Science:

    • Gynecology
    • Reproductive Health
    • Gerontology

    Background:

    • Urogenital atrophy is a frequent condition in postmenopausal or castrated women.
    • Its etiology is multifactorial, with age and estrogen deprivation often intertwined.
    • Clinical presentation can be highly varied.

    Purpose of the Study:

    • To review the common condition of urogenital atrophy in postmenopausal women.
    • To discuss the multifactorial etiology and varied clinical presentations.
    • To evaluate the role and risks of estrogen replacement therapy.

    Main Methods:

    • Literature review on urogenital atrophy and estrogen therapy.
    • Analysis of factors contributing to urogenital atrophy.
    • Discussion of clinical management strategies.

    Related Experiment Videos

    Main Results:

    • Urogenital atrophy presents with diverse symptoms in postmenopausal women.
    • Estrogen deprivation significantly contributes to atrophy, often alongside aging.
    • Estrogen replacement therapy effectively alleviates atrophic symptoms.

    Conclusions:

    • Urogenital atrophy is a prevalent condition with complex causes.
    • Estrogen therapy is a viable treatment option for symptom relief.
    • Careful surveillance is essential during estrogen replacement to mitigate risks.